2021
DOI: 10.4103/ijrh.ijrh_96_19
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical updates of the homoeopathic medicines used in diabetes mellitus: A narrative review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…1 . Similarly, majority of preclinical research in DM in homoeopathy was carried on drugs like Syzygium jambolanum and Cephalandra indica [ 49 ] which are the two most common organospecific remedies reported in the present study. There are several limitations to this study.…”
Section: Discussionmentioning
confidence: 80%
“…1 . Similarly, majority of preclinical research in DM in homoeopathy was carried on drugs like Syzygium jambolanum and Cephalandra indica [ 49 ] which are the two most common organospecific remedies reported in the present study. There are several limitations to this study.…”
Section: Discussionmentioning
confidence: 80%
“…12 Syzygium jambolanum and Cephalandra indica mother tinctures have been used successfully in the management of T2DM. 13 Two multicenter studies have suggested a promising role for homeopathic treatment in diabetic distal symmetric polyneuropathy. 14 15…”
Section: Introductionmentioning
confidence: 99%
“…12 Syzygium jambolanum and Cephalandra indica mother tinctures have been used successfully in the management of T2DM. 13 Two multicenter studies have suggested a promising role for homeopathic treatment in diabetic distal symmetric polyneuropathy. 14,15 This randomized controlled trial (RCT) was the first attempt at exploring the efficacy of IHMs in individuals with PD in comparison with placebos.…”
Section: Introductionmentioning
confidence: 99%